OraSure Subsidiary DNA Genotek's OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva TestGlobeNewsWire • 01/29/21
OraSure Subsidiary DNA Genotek's OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 TestingGlobeNewsWire • 01/28/21
OraSure's OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing ProgramGlobeNewsWire • 01/26/21
OraSure's Oragene®•Dx Saliva Collection Kit Included in Industry's First FDA Authorization for a Whole Exome Sequencing PlatformGlobeNewsWire • 01/21/21
OraSure: Well Positioned Ex-Covid, Sell Side Missing The Organic Growth DriversSeeking Alpha • 01/12/21
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/05/21
OraSure's OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 TestGlobeNewsWire • 12/23/20
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody TestGlobeNewsWire • 12/21/20
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/30/20
OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing BellGlobeNewsWire • 11/30/20
OraSure Technologies to Present at the Stephens Annual Investment Conference 2020GlobeNewsWire • 11/12/20
Stock Upgrades: Orasure Technologies Shows Rising Relative StrengthInvestors Business Daily • 11/09/20
OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
OraSure Technologies (OSUR) Beats Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/04/20
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 DevelopmentsGlobeNewsWire • 11/04/20
OraSure's DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Device for SARS CoV-2GlobeNewsWire • 11/03/20
OraSure's Emergency Use Authorization, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 10/22/20
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ETGlobeNewsWire • 10/21/20
OraSure's OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2GlobeNewsWire • 10/19/20